Drug Shortage Report for MYLAN-AMLODIPINE/ATORVASTATIN
| Report ID | 103957 |
| Drug Identification Number | 02362821 |
| Brand name | GD-AMLODIPINE/ATORVASTATIN |
| Common or Proper name | Amlodipine/Atorvastatin |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | AMLODIPINE ATORVASTATIN |
| Strength(s) | 10MG 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90's |
| ATC code | C10BX |
| ATC description | LIPID MODIFYING AGENTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-01-22 |
| Estimated end date | |
| Actual end date | 2020-04-21 |
| Shortage status | Resolved |
| Updated date | 2020-04-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2020-04-22 | French | Compare |
| v10 | 2020-04-22 | English | Compare |
| v9 | 2020-03-31 | French | Compare |
| v8 | 2020-03-31 | English | Compare |
| v7 | 2020-03-31 | French | Compare |
| v6 | 2020-03-31 | English | Compare |
| v5 | 2020-02-18 | French | Compare |
| v4 | 2020-02-18 | English | Compare |
| v3 | 2020-01-23 | English | Compare |
| v2 | 2020-01-22 | French | Compare |
| v1 | 2020-01-22 | English | Compare |
Showing 1 to 11 of 11